课题基金 / 基金详情

Targeting host deubiquitinases for broad spectrum anti-infective therapy

Targeting host deubiquitinases for broad spectrum anti-infective therapy
靶向宿主去泛素酶进行广谱抗感染治疗
批准号:
8485542
负责人:
Mary O'Riordan
金额:
$22.82万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2014-07-14

项目摘要

项目成果

Mary O'Riordan的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):迫切需要新的治疗方法来有效靶向目前没有治疗选择的耐药微生物和病原体。诺如病毒每年在美国造成约2300万例感染,占所有食源性胃肠炎爆发的一半以上,但目前还没有抗病毒药物或疫苗来治疗或预防感染。单核细胞增生李斯特菌是另一种食源性病原体,致死率为20 - 25%,是最近香瓜相关食源性感染爆发的原因。有一个令人信服的理由,发展广谱疗法的早期和有效的治疗传染病。实现这一目标的一种方法是开发“抗感染”化合物,其靶向病原体感染期间至关重要的宿主编码蛋白质。 泛素是一种真核生物低分子量多肽,当与靶蛋白共价连接时充当翻译后调节开关。 本申请提供了显示小分子WP 1130(WP)和相关化合物对不同种类的病原体具有抗感染活性的初步数据,所述病原体包括:B类细菌(MRSA、单核细胞增生李斯特菌、鼠伤寒沙门氏菌血清型);病毒(鼠和人诺如病毒、脑心肌炎病毒、辛德毕斯病毒、拉克罗斯病毒);和顶复门寄生虫(刚地弓形虫)。 WP抑制宿主细胞去泛素化酶(DUB)的一个子集,导致泛素化蛋白的积累。 宿主外的病原体不受影响。 使用WP类似物的研究为开发新的疗法提供了重要线索,这些疗法可以通过干扰关键的宿主和微生物相互作用来有效地控制病原体。宿主靶标的泛素化和去泛素化在许多微生物感染中具有关键作用。 我们假设WP可以通过选择性抑制微生物病原体利用的DUB来限制感染。我们将使用鼠诺如病毒和L。单核细胞增多症和建立感染的小动物模型,以确定介导WP抗感染作用的DUB靶标。我们的目标是选择用于研究性新药(IND)申请的先导化合物。我们提出了以下具体目标:(1)确定介导抗感染活性的WP的靶DUB,(2)体外测试SAR系列WP以鉴定先导化合物,以及(3)测试先导化合物的体内功效。本申请提出开发广谱抗感染治疗剂,其对包括多种B类试剂的许多病原体具有功效。
英文摘要
DESCRIPTION (provided by applicant): There is an urgent need for new therapeutics to effectively target drug-resistant microbes and pathogens that currently have no treatment options. Noroviruses cause an estimated 23 million infections and over half of all food-borne gastroenteritis outbreaks in the US every year yet no antivirals or vaccines exist to treat or prevent infections. Listeria monocytogenes is another food-borne pathogen with a 20 - 25% fatality rate, responsible for recent cantaloupe-associated food-borne infection outbreaks. There is a compelling rationale for developing broad-spectrum therapeutics for early and effective treatment of infectious diseases. One approach towards that goal is development of "anti-infective" compounds that target host-encoded proteins critical during pathogen infection. Ubiquitin is a eukaryotic low molecular weight polypeptide that acts as a post-translational regulatory switch when covalently linked to target proteins. This application provides preliminary data showing a small molecule, WP1130 (WP) and related compounds have anti-infective activity against different classes of pathogens, including: category B bacteria (MRSA, Listeria monocytogenes, Salmonella enterica serovar Typhimurium); viruses (murine and human norovirus, encephalomyocarditis virus, Sindbis virus, La Crosse virus); and an apicomplexan parasite (Toxoplasma gondii). WP inhibits a subset of host cell deubiquitinases (DUBs), causing accumulation of ubiquitinated proteins. Pathogens outside the host are not affected. Studies using WP analogs provide vital clues for development of novel therapeutics that may effectively control pathogens by interfering with key host and microbe interactions. Ubiquitination and deubiquination of host targets have critical roles in many microbial infections. We hypothesize that WP can limit infection by selectively inhibiting DUBs exploited by microbial pathogens. We will use murine norovirus and L. monocytogenes and established small animal models of infection to define DUB targets that mediate the anti-infective effects of WP. Our goal is to select lead compound to be utilized in an investigational new drug (IND) application. We propose the following specific aims: (1) Determine target DUBs of WP that mediate anti-infective activity, (2) Test a SAR series of WP in vitro to identify lead compounds, and (3) Test lead compounds for in vivo efficacy. This application proposes to develop broad-spectrum anti-infective therapeutics that have efficacy against many pathogens including multiple category B agents.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Small molecule deubiquitinase inhibitors promote macrophage anti-infective capacity.
小分子去泛素酶抑制剂促进巨噬细胞抗感染能力。
DOI: 10.1371/journal.pone.0104096
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Charbonneau ME, Gonzalez-Hernandez MJ, Showalter HD, Donato NJ, Wobus CE, O'Riordan MX]
通讯作者: O'Riordan MX
DOI: 10.1371/journal.pone.0094491
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Gonzalez-Hernandez MJ, Pal A, Gyan KE, Charbonneau ME, Showalter HD, Donato NJ, O'Riordan M, Wobus CE]
通讯作者: Wobus CE
Mitochondrial stress shapes host responses to bacterial infection
Mitochondrial stress shapes host responses to bacterial infection
Mitochondrial stress shapes host responses to bacterial infection
Mechanisms of host defense against membrane damage by pore-forming toxins
海外基金